Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes

被引:94
|
作者
Puppo, F
Contini, P
Ghio, M
Brenci, S
Scudeletti, M
Filaci, G
Ferrone, S
Indiveri, F
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
[2] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
HLA; immunomodulation;
D O I
10.1093/intimm/12.2.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we have evaluated the apoptotic effect of soluble human MHC class I (sHLA-I) antigens on CD8(+) T lymphocytes. sHLA-I antigens and beta(2)-microglobulin-free HLA class I heavy chains, isolated from serum, induced apoptosis on phytohemagglutinin-activated CD8(+) T lymphocytes in autologous and allogeneic combinations. The extent of CD8(+) T cell apoptosis depends on the degree of activation, time of incubation with sHLA-I antigens and amount of sHLA-I antigens added to the cultures. Apoptosis is induced by the interaction of Fas (CD95)(+) cells with soluble Fas ligand which is released following binding of sHLA-I antigens to CD8 molecules. These results suggest that sHLA-I antigens may regulate immune responses by inducing apoptosis in activated CD8(+) T cells.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 50 条
  • [41] HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand
    Noraz, N
    Gozlan, J
    Corbeil, J
    Brunner, T
    Spector, SA
    AIDS, 1997, 11 (14) : 1671 - 1680
  • [42] IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells
    Mueller, YM
    Makar, V
    Bojczuk, PM
    Witek, J
    Katsikis, PD
    INTERNATIONAL IMMUNOLOGY, 2003, 15 (01) : 49 - 58
  • [43] Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
    Zavazava, N
    Kronke, M
    NATURE MEDICINE, 1996, 2 (09) : 1005 - 1010
  • [44] Heightened CD95 (Fas)-CD95L (Fas ligand) interactions and T cell apoptosis in stable cardiac transplant recipients: A potential mechanism for tolerance induction.
    Ankersmit, J
    Moser, B
    Hofmann, M
    Schuster, MD
    Karimova, A
    Wolf, I
    Hericis, R
    Grimm, M
    Kocher, AA
    Edwards, NM
    Wolner, E
    Itescu, S
    TRANSPLANTATION, 2000, 69 (08) : S250 - S250
  • [45] Dendritic cells inhibit CD95/Fas-triggered apoptosis of activated T lymphocytes by a mechanism upstream of caspase-activation.
    Daniel, PT
    Scholz, C
    Essmann, F
    Westermann, J
    Pezzutto, A
    Dörken, B
    BLOOD, 1999, 94 (10) : 688A - 688A
  • [46] Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis
    Tanner, JE
    Alfieri, C
    BLOOD, 1999, 94 (10) : 3439 - 3447
  • [47] Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia
    Tinhofer, I
    Marschitz, I
    Kos, M
    Henn, T
    Egle, A
    Villunger, A
    Greil, R
    BLOOD, 1998, 91 (11) : 4273 - 4281
  • [48] Keratinocytes express in addition to fas (APO-1/CD95) its ligand Fas-L and secrete soluble fas which might protect keratinocytes from autocrine Fas-mediated apoptosis.
    Maeda, A
    Aragane, Y
    Schwarz, A
    Luger, T
    Schwarz, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 187 - 187
  • [49] A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas
    Graves, JD
    Draves, KE
    Craxton, A
    Krebs, EG
    Clark, EA
    JOURNAL OF IMMUNOLOGY, 1998, 161 (01): : 168 - 174
  • [50] NFAT binding sites participate in regulation of the CD95 (Fas) ligand promoter in activated T cells.
    Latinis, KM
    Norian, LA
    Koretzky, GA
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1743 - 1743